共 50 条
- [2] Randomized, double-blind, placebo-controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1303 - 1303
- [4] LY2439821, a Humanized Anti-Interleukin-17 Monoclonal Antibody, in the Treatment of Patients With Rheumatoid Arthritis A Phase I Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study ARTHRITIS AND RHEUMATISM, 2010, 62 (04): : 929 - 939
- [5] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CD4 MONOCLONAL-ANTIBODY THERAPY IN EARLY RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1995, 38 (08): : 1097 - 1106
- [7] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study Rheumatology International, 2006, 26 : 1132 - 1137
- [8] Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis - A phase I/II randomized, blinded, placebo-controlled, dose-ranging study ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : 2652 - 2661
- [9] Mavrilimumab (an Anti-GM-CSFRα Monoclonal Antibody) in Subjects with Rheumatoid Arthritis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4044 - 4044
- [10] A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1102 - 1108